Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Yeramian Patrick D
Chief Medical Officer at Amylyx Pharmaceuticals. Filing since 6 Jan 2023.
CIK 0001358266
Company
Date
Role
Action
Shares
Amount
Of holding
AMLX
Amylyx Pharmaceuticals, Inc.
9 Jan 2024
Chief Medical Officer
Sold at will
2,812
$45.91K
1.3%
AMLX
Amylyx Pharmaceuticals, Inc.
15 May 2023
Chief Medical Officer
Sold on a plan
11,965
$347.36K
5.4%
AMLX
Amylyx Pharmaceuticals, Inc.
17 Apr 2023
Chief Medical Officer
Sold on a plan
49,579
$1.51M
19.2%
AMLX
Amylyx Pharmaceuticals, Inc.
16 Mar 2023
Chief Medical Officer
Sold at will
54,627
$1.74M
26.7%
AMLX
Amylyx Pharmaceuticals, Inc.
6 Jan 2023
Chief Medical Officer
Bought
2,034
$73.83K
1.0%
5 decisions on file.